TICKERNERD
Menu
NXGLNXGLHealthcare · Medical Instruments & Supplies

NXGL Stock Forecast: NexGel, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026
$0.27
+2.63% on the day

The 1 Wall Street analysts covering NexGel, Inc. hold a median 12-month price target of $2 — +652.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 12 of 100 as at 19 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$2.5M
Ticker Nerd rank
12 / 100
Median analyst target
$2.00
Analysts covering
1
Revenue$3.7M+27.8% y/y
Operating income−$2.5M
Net income−$3.6M
Free cash flow−$8.8M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−8.7%
1M
−31.0%
YTD
−83.5%
1Y
−89.7%
From 52W high
−90.4%
From 52W low
+7.2%
$0.25
$2.78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NXGL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores NexGel, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
12 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
98
Quality
40
Accruals
39
Revisions
31
Value
27
Volatility
24
Momentum
18
Issuance
9
Growth
6

Size (98): Smaller than most of the companies we track.

Growth (6): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NXGL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NXGL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$0.50$1.00$1.50$2.00$2.50$3.00Oct 25Jan 26Apr 26Jul 26NXGLHigh $2.00Median $2.00Low $2.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
0 Buy1 Hold0 Sell
Low $2.00Median $2.00High $2.00

The green dot is the last close — the median target sits +652.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
24 Aug 2026Maxim GroupDowngradeHold—
12 Mar 2026Maxim GroupMaintainsBuy$6.00 → $2.00
12 Mar 2026Maxim GroupMaintainsBuy—
25 Feb 2022Maxim GroupInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NXGL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

NXGL vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, NexGel, Inc. returned −89.7% against +16.3% for the S&P 500, dividends included.

NXGL vs S&P 500, last 12 monthsTotal return, rebased to 100
020406080100120Oct 25Jan 26Apr 26Jul 26NXGLS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NXGL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

NexGel, Inc. (NXGL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.7×

Cheaper than 81% of US stocks

Price / sales
0.2×

Cheaper than 92% of US stocks

Price / book
0.5×

Cheaper than 84% of US stocks

EV / EBITDA
−2.4×

Cheaper than 73% of US stocks

Growth & margins
Revenue growth (YoY)
27.8%

Higher than 77% of US stocks

Earnings growth (YoY)
27.8%

Higher than 64% of US stocks

Gross margin
30.1%

Higher than 34% of US stocks

Operating margin
−68.0%

Higher than 15% of US stocks

Net margin
−51.3%

Higher than 10% of US stocks

Returns & dividend
Return on equity
−115.1%

Higher than 12% of US stocks

Return on assets
−18.7%

Higher than 20% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

NexGel, Inc. (NXGL) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • NexGel, Inc. has a market value of $2.5M and an enterprise value of $10.0M.

  • Revenue in the twelve months to 30 June 2026: $12.1M. The latest quarter grew 27.8% year on year.

  • Net income over the same four quarters: −$6.1M, a −50.2% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$9.8M.

  • Shares outstanding: 9.2M.

  • Trailing P/E: −0.7×; forward P/E: −1.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • NexGel, Inc. employs 19 people — $635K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 18 Sept 2026

Data provided by Twelve Data

Peers

NXGL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
NXGLNexGel, Inc.$2.5M
12
LUCYInnovative Eyewear, Inc.$8.2M
20
CUPRCuprina Holdings (Cayman) Ltd.$9.4M
4
RGNTRegentis Biomaterials Ltd.$12.7M
8
BNGOBionano Genomics, Inc.$20.4M
78
RVPRetractable Technologies, Inc.$21.5M
60
FEMYFemasys, Inc.$21.7M
43

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own NexGel, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NXGL news & analysis

NEXGEL Announces Date for Investor Update Call

GlobeNewsWire · 16 Sept 2026neutral

NEXGEL, Inc. announced that its investor update call, originally referenced in its August 17, 2026 earnings release, will now be hosted on September 24, 2026, at 4:15 p.m. Eastern Time. The call had previously been expected on or around September 15, 2026.

Why it matters — NEXGEL watchers will want to note the revised date for the scheduled investor update call to stay informed on the company's corporate communications.

FAQ

Frequently asked questions about NXGL stock

What is the NXGL stock price forecast for 2026-2027?

The 1 Wall Street analysts covering NexGel, Inc. have a median 12-month price target of $2, with estimates ranging from $2 to $2. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NXGL stock a buy right now?

Of the 1 analysts covering NexGel, Inc., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NexGel, Inc. 12 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NXGL?

As at 19 Sept 2026, NexGel, Inc. ranks 12 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (98 of 100).

Will NXGL stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +652.4% from the last close, and Ticker Nerd's factor model ranks NexGel, Inc. 12 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NXGL stock forecast for 2030?

No analyst covering NexGel, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NXGL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $2 over the next 12 months.

How has NXGL stock performed over the past year?

NexGel, Inc. returned -89.7% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does NexGel, Inc. do?

NexGel Inc. is a healthcare and consumer products company that develops and manufactures high-water-content hydrogels and gel-based formulations for wound care, medical diagnostics, transdermal drug delivery, cosmetics, and over-the-counter remedies.

What is the latest news on NXGL?

The most recent item we track (GlobeNewsWire, 16 Sept 2026): "NEXGEL Announces Date for Investor Update Call". NEXGEL, Inc. announced that its investor update call, originally referenced in its August 17, 2026 earnings release, will now be hosted on September 24, 2026, at 4:15 p.m. Eastern Time. The call had previously been expected on or around September 15, 2026.

Company

About NexGel, Inc.

NexGel Inc. is a healthcare and consumer products company that develops and manufactures high-water-content hydrogels and gel-based formulations for wound care, medical diagnostics, transdermal drug delivery, cosmetics, and over-the-counter remedies. The company’s platform focuses on ultra-gentle, skin-friendly materials designed for applications that require comfortable wear, controlled delivery, and broad formulation flexibility. NexGel serves both healthcare and consumer markets through products used in blister care, pain relief, beauty, and cosmetic applications, while also supporting contract manufacturing relationships with other consumer health companies. Its business is organized around hydrogel manufacturing and converting and packaging operations, reflecting a mix of proprietary material science and outsourced product support services. Based in Langhorne, Pennsylvania, NexGel plays a niche role in the specialty materials segment of the healthcare market.

CEO Mr. Brian J. Kieser C.P.A. · 19 employees · United States · https://nexgel.com